FDA inspection
Aurobindo Pharma USA Inc: FDA inspection ending May 30, 2012
FDA inspection 783745 · No Action Indicated (NAI) · East Windsor, NJ
Key facts
| Inspection ID | 783745 |
|---|---|
| Firm | Aurobindo Pharma USA Inc |
| FEI number | 3008460374 |
| Address | 6 Wheeling Rd |
| City | East Windsor |
| State | NJ |
| ZIP | 08520 |
| Country | United States |
| Fiscal year | 2012 |
| Inspection end date | May 30, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data